Literature DB >> 4623319

Immune status of mice tolerant of living cells. II. Continuous presence and nature of facilitation-enhancing antibodies in tolerant animals.

G A Voisin, R G Kinsky, H T Duc.   

Abstract

CBA mice were rendered highly tolerant to A/Jax cells by neonatal intravenous injections of (CBA x A)F(1) spleen cells. The high degree of tolerance was ascertained by the absence of circulating antibodies detected in the sera by the usual tests and by the perfect state of A skin grafts during all the experiments. Tolerant sera (sera from tolerant animals) were studied at three periods of tolerance: before skin test grafting, from 2 to 11 wk after grafting, and at time of sacrifice at almost 6 months of age. The tolerant sera were shown to have specific facilitation-enhancing properties promoting the take and growth of A/Jax sarcoma (SaI and /Sa 15091a grafted on normal CBA mice. These properties were present throughout the duration of the experiments, showing that they were not the result of a beginning interruption of tolerance. The tolerant sera, although lacking the usual serological properties (hemagglutination, hemolysis, cytotoxicity, passive cutaneous anaphylaxis) had, however, specific synergistic hemagglutinating properties (increasing the hemagglutinating titer of a reference immune serum). Antibodies giving direct specific hemagglutination could be extracted from spleens of 20% of highly tolerant mice. The tolerant sera were also found to contain more IgG1 and more IgA than normal sera while they contained normal quantities of the complement-fixing immunoglobulins IgG2 and IgM. Fractionation of tolerant sera on DEAE chromatography column confirmed the data concerning immunoglobulin classes and demonstrated direct specific serological activities undetected in unfractionated sera: a weak hemolysis in the most cationic fractions and a weak hemagglutination in the middle fractions. Synergistic hemagglutination, detected in unfractionated serum, was localized in fast anionic fractions containing high IgA concentration, along with facilitation-enhancing activity, thus confirming a link suggested previously between these three properties. The relation between immunological tolerance and facilitating antibodies was discussed in the light of the fact that antibodies, possibly of a particular class continuously present at low dose in the sera of highly tolerant animals, are able to transfer (at least partly) this state of tolerance provided a sensitive test system is utilized.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4623319      PMCID: PMC2138981          DOI: 10.1084/jem.135.5.1185

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  32 in total

1.  Investigation of the mechanisms by whick "enhancing" antiserum prevents induction of delayed hypersensitivity to protein antigens in mice.

Authors:  A J Crowle; C C Hu
Journal:  J Allergy       Date:  1969-04

2.  Transplantation immunity: localization in mouse serum of antibodies responsible for haemagglutination, cytotoxicity and enhancement.

Authors:  G A Voisin; R G Kinsky; F K Jansen
Journal:  Nature       Date:  1966-04-09       Impact factor: 49.962

3.  [Immune reaction and facilitating antibodies in animals tolerating homografts].

Authors:  G A Voisin; R G Kinsky; J Maillard
Journal:  Ann Inst Pasteur (Paris)       Date:  1968-11

4.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

5.  Protection against homologous disease in hybrid mice by passive and active immunological enhancement-facilitation.

Authors:  G A Voisin; R Kinsky; J Maillard
Journal:  Transplantation       Date:  1968-03       Impact factor: 4.939

6.  Immunological enhancement by mouse isoantibodies: the importance of complement fixation.

Authors:  T Chard
Journal:  Immunology       Date:  1968-04       Impact factor: 7.397

7.  Selective and specific inhibition of 24 hour skin reactions in the guinea-pig. I. Immune deviation: description of the phenomenon and the effect of splenectomy.

Authors:  G L Asherson; S H Stone
Journal:  Immunology       Date:  1965-09       Impact factor: 7.397

8.  Enhancement of the C57BL leukemia E.L.4 by Fab fragments of isoantibody.

Authors:  T Chard; M E French; J R Batchelor
Journal:  Transplantation       Date:  1967-09-05       Impact factor: 4.939

9.  [Protection against runting disease by immunologic facilitation (enhancement phenomenon) induced passively and actively].

Authors:  G A Voisin; R Kinsky; J Maillard
Journal:  Ann Inst Pasteur (Paris)       Date:  1967-10

10.  The mixed lymphocyte reaction: an in vitro test for tolerance.

Authors:  M R Schwarz
Journal:  J Exp Med       Date:  1968-05-01       Impact factor: 14.307

View more
  11 in total

1.  Facilitation reaction (enhancing antibodies and suppressor cells) and rejection reaction (sensitized cells) from the mother to the paternal antigens of the conceptus.

Authors:  G Chaouat; G A Voisin; D Escalier; P Robert
Journal:  Clin Exp Immunol       Date:  1979-01       Impact factor: 4.330

Review 2.  Classification of immunological unresponsiveness and tolerance.

Authors:  G L Asherson; R M Barnes
Journal:  Proc R Soc Med       Date:  1973-05

3.  Allograft tolerance: presumptive evidence that serum factors from tolerant animals that block lymphocyte-mediated immunity in vitro are soluble antigen-antibody complexes.

Authors:  P W Wright; R E Hargreaves; S C Bansal; I D Bernstein; K E Hellström
Journal:  Proc Natl Acad Sci U S A       Date:  1973-09       Impact factor: 11.205

4.  Autoimmune disease and malignant lymphoma associated with host-versus-graft disease in mice.

Authors:  M Tateno; N Kondo; T Itoh; T Yoshiki
Journal:  Clin Exp Immunol       Date:  1985-12       Impact factor: 4.330

5.  Blastogenic suppression and alloantibody activity of sera from renal allograft recipients.

Authors:  A H Johnson; R D Rossen; E M Hersh; S S Farrow; W T Butler; W N Suki
Journal:  J Clin Invest       Date:  1974-01       Impact factor: 14.808

6.  Mixed leucocyte culture blocking factor activity in allograft recipients and its role in the clinical outcome of human cadaveric renal allografts.

Authors:  D P Sengar; A Rashid; J E Harris
Journal:  Clin Exp Immunol       Date:  1975-12       Impact factor: 4.330

Review 7.  Reproductive immunology: biomarkers of compromised pregnancies.

Authors:  W P Faulk; C B Coulam; J A McIntyre
Journal:  Environ Health Perspect       Date:  1987-10       Impact factor: 9.031

8.  Recirculating, suppressor T cells in transplantation tolerance.

Authors:  S Dorsch; R Roser
Journal:  J Exp Med       Date:  1977-05-01       Impact factor: 14.307

9.  Cell-mediated immunity and blocking serum activity to tolerated allografts in rats.

Authors:  S C Bansal; K E Hellström; I Hellström; H O Sjögren
Journal:  J Exp Med       Date:  1973-03-01       Impact factor: 14.307

10.  The mechanism of tolerance induction in thymus-derived lymphocytes; I. intracellular inactivation of hapten-reactive helper T lymphocytes by hapten-nonimmunogenic copolymer of D-amino acids.

Authors:  T Hamaoka; U Yamaskita; T Takami; M Kitagawa
Journal:  J Exp Med       Date:  1975-06-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.